NCT01522378View on ClinicalTrials.gov

Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging

PHASE1TerminatedINTERVENTIONAL

Enrollment

14

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

February 29, 2016

Study Completion Date

February 29, 2016

Conditions

Congestive Heart Failure

Interventions

DRUG

123 iodine metaiodobenzylguanidine

10 millicurie (mCi) (370 MBq)

Trial Locations (1)

55905

Mayo Clinic in Rochester, Rochester

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors

collaborator

GE Healthcare

INDUSTRY

lead

Mayo Clinic

OTHER

NCT01522378 - Cardiac Resynchronization and Iodine Meta-Iodobenzylguanidine (MIBG) Imaging | Biotech Hunter | Biotech Hunter